<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150529022466N15</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-05</date_registration>
      <primary_sponsor>Boushehr University of Medical Sciences</primary_sponsor>
      <public_title>The effect of physical activity during dialysis on dialysis adequacy, hemodynamic indicators and fatigue in patients</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effectiveness of Physical Activity During Dialysis on the Dialysis Adequacy, Hemodynamic Indices and Fatigue in Hemodialysis Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>84</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44806</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: After selecting all available participants based on inclusion criteria, randomization will be done using simple randomization method and statistical software, Blinding description: In the study, each participant will have a code that only the researcher will have access to, and the participant's name will not be specified for the outcomes evaluator and data analyzer. Paraclinical tests performance, record data and enter data into the software for analysis using code and without revealing the study group and name.</study_design>
      <phase>N/A</phase>
      <hc_freetext>End Stage Renal Disease (ESRD), Hemodialysis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients with chronic renal failure with at least three months of hemodialysis undergo exercise for thirty minutes in two 15-minute phases during the first two hours of dialysis. The activity is performed using a pedal that is installed at the bottom of the patient's bed. There is an interval of fifteen minutes for rest during activity. Before the intervention, participants warm up for five minutes and then slowly cool off by pedaling. The pedaling intensity will be such that the patient reaches a 10% increase in pulse rate compared to the pulse rate before starting the activity. The safe range of pulse rate in patients at the time of activity is considered to be a minimum of 50 and a maximum of 125 beats per minute. Intervention 2: Control group: Patients with chronic renal failure with at least three months of hemodialysis will undergo 4-hour routine dialysis.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Shahnaz Pooladi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sabzabad avenue</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7518759577</zip>
        <telephone>+98 77 3345 0187</telephone>
        <email>pouladi2008@yahoo.com</email>
        <affiliation>Boushehr University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Shahnaz Pooladi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of nursing and midwifery, Bushehr University of medical sciences, Rishehr avenue, Sabzabad avenue</address>
        <city>Bushehr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7518759577</zip>
        <telephone>+98 77 3345 0187</telephone>
        <email>pouladi2008@yahoo.com</email>
        <affiliation>Boushehr University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of 18 to 65 years old
History of hemodialysis more than 3 months
Ability to perform walking independently (at least 2 minutes)
4-hour dialysis tolerance in past sessions
No history of hypokalemia (K&lt;3.5 Meq/L)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having problems with the musculoskeletal system
Systolic blood pressure greater than or equal to 160 mmHg or diastolic blood pressure greater than or equal to 120 mmHg
Having vascular access in the lower extremities
History of unstable angina and heart attack in 1 last month
History of congestive heart failure
Treatment with psychotropic drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N18.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic kidney disease, stage 5</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients with chronic renal failure with at least three months of hemodialysis undergo exercise for thirty minutes in two 15-minute phases during the first two hours of dialysis. The activity is performed using a pedal that is installed at the bottom of the patient's bed. There is an interval of fifteen minutes for rest during activity. Before the intervention, participants warm up for five minutes and then slowly cool off by pedaling. The pedaling intensity will be such that the patient reaches a 10% increase in pulse rate compared to the pulse rate before starting the activity. The safe range of pulse rate in patients at the time of activity is considered to be a minimum of 50 and a maximum of 125 beats per minute.</i_keyword>
      <i_keyword>Control group: Patients with chronic renal failure with at least three months of hemodialysis will undergo 4-hour routine dialysis.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Dialysis adequacy which is assessed by measuring the blood urea nitrogen levels before and after dialysis, the amount of fluid excreted from the patient and the weight after dialysis. Timepoint: It is measured before the start of the study and after each dialysis session. Then the average is estimated at the end of the one month study period. Method of measurement: Dialysis adequacy calculation software and Kt / V.</prim_outcome>
      <prim_outcome>Fatigue. Timepoint: Before and after the one month study period. Method of measurement: FSS questionnaire.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: Before and after dialysis and at each dialysis session until the end of the study period. Method of measurement: Using a digital device.</prim_outcome>
      <prim_outcome>Pulse. Timepoint: Before and after dialysis and at each dialysis session until the end of the study period. Method of measurement: Using a digital device.</prim_outcome>
      <prim_outcome>Respiratory rate. Timepoint: Before and after dialysis and at each dialysis session until the end of the study period. Method of measurement: Using an examination by a researcher.</prim_outcome>
      <prim_outcome>Tempreture. Timepoint: Before and after dialysis and at each dialysis session until the end of the study period. Method of measurement: Using a digital device.</prim_outcome>
      <prim_outcome>O2 Saturation. Timepoint: Before and after dialysis and at each dialysis session until the end of the study period. Method of measurement: Using a digital device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Boushehr University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-22</approval_date>
        <contact_name>Ethics committee of Bushehr University of Medical Sciences</contact_name>
        <contact_address>Sabzabad Ave. Bushehr Boushehr Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
